Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
University of New Mexico
mi
from
Albuquerque, NM
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Vanderbilt University
mi
from
Nashville, TN
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Virginia Commonwealth University
mi
from
Richmond, VA
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Washington University
mi
from
St. Louis, MO
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated:  6/19/2014
Yale University
mi
from
New Haven, CT
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
Assessment of Worldwide AKI in Pediatrics, Renal Angina and Epidemiology
Status: Enrolling
Updated: 6/19/2014
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
Use of a Fish Oil-Based Intravenous Lipid Emulsion (Omegaven®) in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
Status: Enrolling
Updated:  6/26/2014
Levine Children's Hospital at Carolinas HealthCare System
mi
from
Charlotte, NC
Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
Use of a Fish Oil-Based Intravenous Lipid Emulsion (Omegaven®) in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury
Status: Enrolling
Updated: 6/26/2014
Levine Children's Hospital at Carolinas HealthCare System
mi
from
Charlotte, NC
Click here to add this to my saved trials
Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass
Early Renal Replacement Therapy vs. Furosemide for Neonates With Oliguria After Cardiopulmonary Bypass
Status: Enrolling
Updated:  6/30/2014
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass
Early Renal Replacement Therapy vs. Furosemide for Neonates With Oliguria After Cardiopulmonary Bypass
Status: Enrolling
Updated: 6/30/2014
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Improving Outcomes After Traumatic Injury: A Goal Management Approach
Status: Enrolling
Updated:  7/2/2014
Vanderbilt University Medical Center
mi
from
Nashville, TN
Improving Outcomes After Traumatic Injury: A Goal Management Approach
Status: Enrolling
Updated: 7/2/2014
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches
In Vivo Determination of THA Kinematics and Sound for Subject Implanted Using Various Surgical Approaches
Status: Enrolling
Updated:  7/7/2014
University of Maryland St. Joseph Medical Center
mi
from
Towson, MD
THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches
In Vivo Determination of THA Kinematics and Sound for Subject Implanted Using Various Surgical Approaches
Status: Enrolling
Updated: 7/7/2014
University of Maryland St. Joseph Medical Center
mi
from
Towson, MD
Click here to add this to my saved trials
THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches
In Vivo Determination of THA Kinematics and Sound for Subject Implanted Using Various Surgical Approaches
Status: Enrolling
Updated:  7/7/2014
Valley Orthopedic Associates ASC
mi
from
Renton, WA
THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches
In Vivo Determination of THA Kinematics and Sound for Subject Implanted Using Various Surgical Approaches
Status: Enrolling
Updated: 7/7/2014
Valley Orthopedic Associates ASC
mi
from
Renton, WA
Click here to add this to my saved trials
Comparing Safety and Efficacy of Dexmedetomidine and Propofol
Comparing Safety and Efficacy of Dexmedetomidine and Propofol in Patients Requiring Sedation for MRI Scanning
Status: Enrolling
Updated:  7/17/2014
Children's Hospital Boston
mi
from
Boston, MA
Comparing Safety and Efficacy of Dexmedetomidine and Propofol
Comparing Safety and Efficacy of Dexmedetomidine and Propofol in Patients Requiring Sedation for MRI Scanning
Status: Enrolling
Updated: 7/17/2014
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Hypothermic Machine Preservation-Phase 2
Hypothermic Machine Preservation of Extended Criteria Liver Allografts for Transplantation
Status: Enrolling
Updated:  7/22/2014
Columbia University
mi
from
New York, NY
Hypothermic Machine Preservation-Phase 2
Hypothermic Machine Preservation of Extended Criteria Liver Allografts for Transplantation
Status: Enrolling
Updated: 7/22/2014
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas
A Prospective Randomized Comparison of Pancreatic Stump Closure Techniques Utilizing an Autologous Falciform Patch and Fibrin Glue Compared to Standard Closure Following Distal Pancreatectomy With or Without Splenectomy
Status: Enrolling
Updated:  8/5/2014
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas
A Prospective Randomized Comparison of Pancreatic Stump Closure Techniques Utilizing an Autologous Falciform Patch and Fibrin Glue Compared to Standard Closure Following Distal Pancreatectomy With or Without Splenectomy
Status: Enrolling
Updated: 8/5/2014
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas
A Prospective Randomized Comparison of Pancreatic Stump Closure Techniques Utilizing an Autologous Falciform Patch and Fibrin Glue Compared to Standard Closure Following Distal Pancreatectomy With or Without Splenectomy
Status: Enrolling
Updated:  8/5/2014
Thomas Jefferson University
mi
from
Philadelphia, PA
An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas
A Prospective Randomized Comparison of Pancreatic Stump Closure Techniques Utilizing an Autologous Falciform Patch and Fibrin Glue Compared to Standard Closure Following Distal Pancreatectomy With or Without Splenectomy
Status: Enrolling
Updated: 8/5/2014
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated:  8/11/2014
Indiana University and the Rehabilitation Hospital of Indiana
mi
from
Indianapolis, IN
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated: 8/11/2014
Indiana University and the Rehabilitation Hospital of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated:  8/11/2014
Spaulding Rehabilitation
mi
from
Boston, MA
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated: 8/11/2014
Spaulding Rehabilitation
mi
from
Boston, MA
Click here to add this to my saved trials
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated:  8/11/2014
Carolinas Rehabilitation
mi
from
Charlotte, NC
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated: 8/11/2014
Carolinas Rehabilitation
mi
from
Charlotte, NC
Click here to add this to my saved trials
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated:  8/11/2014
Ohio State University
mi
from
Columbus, OH
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated: 8/11/2014
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated:  8/11/2014
TIRR Memorial Herman
mi
from
Houston, TX
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated: 8/11/2014
TIRR Memorial Herman
mi
from
Houston, TX
Click here to add this to my saved trials
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated:  8/11/2014
Univ of Washington
mi
from
Seattle, WA
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study
Status: Enrolling
Updated: 8/11/2014
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Nicotine Administration and Post-operative Opioid Use With Bariatric Surgery
A Randomized, Double Blind, Study to Evaluate the Efficacy of Nasal Nicotine Spray to Reduce Post-Operative Opioid Requirements in Nonsmokers in Elective Laparoscopic Bariatric Surgical Patients
Status: Enrolling
Updated:  8/11/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Nicotine Administration and Post-operative Opioid Use With Bariatric Surgery
A Randomized, Double Blind, Study to Evaluate the Efficacy of Nasal Nicotine Spray to Reduce Post-Operative Opioid Requirements in Nonsmokers in Elective Laparoscopic Bariatric Surgical Patients
Status: Enrolling
Updated: 8/11/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
Status: Enrolling
Updated:  8/11/2014
Craig Hospital
mi
from
Englewood, CO
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy
Status: Enrolling
Updated: 8/11/2014
Craig Hospital
mi
from
Englewood, CO
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Louisville, KY
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Orange, CA
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
San Diego, CA
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Morgantown, WV
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Shreveport, LA
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Boston, MA
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Jackson, MS
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Omaha, NE
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Akron, OH
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Cleveland, OH
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Toledo, OH
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Austin, TX
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Houston, TX
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Houston, TX
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated:  8/26/2014
Clinical Research Facility
mi
from
Little Rock, AR
Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections
A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Infection
Status: Enrolling
Updated: 8/26/2014
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis
Surveillance and Risk Factor Analysis of Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis in the United States
Status: Enrolling
Updated:  10/15/2014
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis
Surveillance and Risk Factor Analysis of Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis in the United States
Status: Enrolling
Updated: 10/15/2014
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Click here to add this to my saved trials
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™
A Pilot Clinical Evaluation of the Antimicrobial Effectiveness of Topically Applied ZuraPrep™
Status: Enrolling
Updated:  10/24/2014
BioSciences Laboratories, Inc.
mi
from
Bozeman, MT
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™
A Pilot Clinical Evaluation of the Antimicrobial Effectiveness of Topically Applied ZuraPrep™
Status: Enrolling
Updated: 10/24/2014
BioSciences Laboratories, Inc.
mi
from
Bozeman, MT
Click here to add this to my saved trials
Phase I STEBVax in Healthy Adults
Phase I Study of the Safety and Immunogenicity of Recombinant Staphylococcal Enterotoxin B Vaccine (STEBVax) in Healthy Adults
Status: Enrolling
Updated:  10/30/2014
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
mi
from
Baltimore, MD
Phase I STEBVax in Healthy Adults
Phase I Study of the Safety and Immunogenicity of Recombinant Staphylococcal Enterotoxin B Vaccine (STEBVax) in Healthy Adults
Status: Enrolling
Updated: 10/30/2014
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD
Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD
Status: Enrolling
Updated:  10/31/2014
Dayton VA Medical Center
mi
from
Dayton, OH
Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD
Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD
Status: Enrolling
Updated: 10/31/2014
Dayton VA Medical Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD
Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD
Status: Enrolling
Updated:  10/31/2014
Dayton VA Medical Center
mi
from
Dayton, OH
Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD
Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD
Status: Enrolling
Updated: 10/31/2014
Dayton VA Medical Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation
Effects of Inhaled Nitric Oxide on Ischemia-Reperfusion Injury in Human Liver During Transplantation
Status: Enrolling
Updated:  11/5/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation
Effects of Inhaled Nitric Oxide on Ischemia-Reperfusion Injury in Human Liver During Transplantation
Status: Enrolling
Updated: 11/5/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation
Effects of Inhaled Nitric Oxide on Ischemia-Reperfusion Injury in Human Liver During Transplantation
Status: Enrolling
Updated:  11/5/2014
Univ of Washington
mi
from
Seattle, WA
Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation
Effects of Inhaled Nitric Oxide on Ischemia-Reperfusion Injury in Human Liver During Transplantation
Status: Enrolling
Updated: 11/5/2014
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
Evaluate the Utility of Shear Wave Sonoelastography as a Tool to Measure Liver Fibrosis Grade.
Status: Enrolling
Updated:  11/16/2014
Massachusetts General Hospital
mi
from
Boston, MA
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
Evaluate the Utility of Shear Wave Sonoelastography as a Tool to Measure Liver Fibrosis Grade.
Status: Enrolling
Updated: 11/16/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials